These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1430782)

  • 1. Attempted use of zinc in vivo to protect against nitrogen mustard toxicity in tumor-free and in L1210 leukemia-bearing female B6D2F1 mice.
    Shackelford ME; Tobey RA
    J Appl Toxicol; 1992 Aug; 12(4):295-300. PubMed ID: 1430782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary report on the use of zinc in vivo to protect against nitrogen mustard toxicity in female Balb/cJ mice.
    Shackelford ME; Tobey RA
    J Appl Toxicol; 1992 Aug; 12(4):291-3. PubMed ID: 1430781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
    Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
    Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
    Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG
    Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.
    Yagi MJ; Bekesi JG
    Cancer Chemother Pharmacol; 1990; 26(3):215-20. PubMed ID: 2357770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of zinc administration on the growth of L1210 and BW5147 tumors in mice.
    Phillips JL; Sheridan PJ
    J Natl Cancer Inst; 1976 Aug; 57(2):361-3. PubMed ID: 1003517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo anti-tumor activity of L-glutamic acid gamma-monohydroxamate against L1210 leukemia and B16 melanoma.
    Vila J; Thomasset N; Navarro C; Doré JF
    Int J Cancer; 1990 Apr; 45(4):737-43. PubMed ID: 2323850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies.
    Geroni C; Pesenti E; Tagliabue G; Ballinari D; Mongelli N; Broggini M; Erba E; D'Incalci M; Spreafico F; Grandi M
    Int J Cancer; 1993 Jan; 53(2):308-14. PubMed ID: 8425770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cytotoxicity of single dose and infusion of alkylating agents.
    Valeriote F; Vietti T
    Cancer Drug Deliv; 1985; 2(1):11-8. PubMed ID: 4052923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNU 157977: a new potent antitumour agent exhibiting low in vivo toxicity in mice injected with L1210 leukaemia cells.
    Baraldi PG; Balboni G; Romagnoli R; Spalluto G; Cozzi P; Geroni C; Mongelli N; Rutigliano C; Bianchi N; Gambari R
    Anticancer Drug Des; 1999 Feb; 14(1):71-6. PubMed ID: 10363029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of tetraacetylglucosamine mustard.
    Wampler GL; Nassiri SK; Hsiao YY; Bardos TJ; Regelson W
    Cancer Res; 1975 Aug; 35(8):1903-6. PubMed ID: 1149014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by taurine of the toxicity of taumustine, a compound with antitumor activity.
    Pierson HF; Fisher JM; Rabinovitz M
    J Natl Cancer Inst; 1985 Nov; 75(5):905-9. PubMed ID: 3863989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
    Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antineoplastic and cytogenetic effects by the combined action of two homo-aza-steroidal esters of nitrogen mustards on P388 and L1210 leukaemias in vivo and in vitro.
    Nikolaropoulos S; Tsavdaridis D; Arsenou E; Papageorgiou A; Karaberis E; Mourelatos D
    Anticancer Res; 2000; 20(4):2745-51. PubMed ID: 10953353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol mustard cytotoxicity in vitro toward murine leukemia and bone marrow progenitor cells.
    Naujokaitis SA; Fisher JM; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):305-18. PubMed ID: 7302378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
    Holm B; Jensen PB; Sehested M
    Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
    Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
    Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonic enhancement of nitrogen mustard cytotoxicity in mouse leukemia.
    Kremkau FW; Kaufmann JS; Walker MM; Burch PG; Spurr CL
    Cancer; 1976 Apr; 37(4):1643-7. PubMed ID: 1260681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileukemic effect of homo-aza-steroidal ester of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid.
    Wampler GL; Catsoulacos P
    Cancer Treat Rep; 1977; 61(1):37-41. PubMed ID: 861962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumour activity of 1-naphthol against L1210 leukaemia in vivo and Ehrlich ascites tumour cells in vivo and in vitro.
    Jones M; d'Arcy Doherty M; Cohen GM
    Cancer Lett; 1986 Dec; 33(3):347-54. PubMed ID: 3802063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.